Archive for Partner news

Creavo Medical Technologies closes £13.4m ($17m) funding round

Creavo Medical Technologies closes £13.4m ($17m) funding round

Creavo Medical Technologies, a Medical Technologies IKC partner, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s funding target, reflecting strong investor support and endorsement of Creavo’s strategy and team. Led by IP Group plc, the developer of intellectual property-based businesses and working with […]

Read More

Innovate UK-MoST funding for treatment of early osteoarthritis

A Proof of Concept Award funded as part of our partnership with Arthritis Research UK in 2015 has successfully secured a £2m Innovate UK-MoST grant, under UK-China Research and Innovation Bridges Competition 2015 scheme. The grant was awarded to continue the development of novel osteochondral scaffold technology for early intervention of osteoarthritis. Osteochondral scaffold technology, […]

Read More
World-leading medical engineering shown to Minister

World-leading medical engineering shown to Minister

Cutting-edge developments in medical technology have been demonstrated to Government Health Minister Lord Prior, during a fact-finding mission to Leeds. Both the University of Leeds and Leeds Teaching Hospitals NHS Trust have built up significant expertise in this field, much of it through partnership working and sharing the expertise of staff. The University has a […]

Read More
Creavo’s Vitalscan receives CE mark

Creavo’s Vitalscan receives CE mark

Creavo’s Vitalscan receives CE mark Creavo Medical Technologies, an emerging British company developing diagnostics technology for acute medical settings, is today (24 November 2016) pleased to announce that its first device, Vitalscan, has received CE mark registration, enabling market launch in Europe. The successful receipt of the CE mark means that the device will now […]

Read More
University to lead medical technologies audit

University to lead medical technologies audit

A University of Leeds-led consortium has been chosen by the Government to carry out an audit of research, innovation and industry in medical technologies. The Science Innovation Audit contract, announced in today’s Autumn Statement, was awarded in recognition of the Leeds City Region consortium’s significant expertise and strength in this field. The audit will explore how […]

Read More

University of Leeds awarded £3.7m to fund knee therapy research

The University of Leeds has been awarded £3.7m by the EPSRC to develop novel testing methods for new knee therapies to treat osteoarthritis and other conditions. The research at Leeds will be led by Professor Ruth Wilcox, Director of the Institute of Medical and Biological Engineering, and will aim to develop novel testing methods for new knee […]

Read More

Tissue Regenix featured on Discovery Channel

Tissue Regenix Group, the regenerative medical devices company and IKC partner, has been featured on an upcoming episode of Innovations with Ed Begley Jr., airing via the Discovery Channel on Thursday 21 July at 7:30aET/7:30aPT. The show travels to Curitiba, Brazil to see how Tissue Regenix unique dCELL® technology is transforming the lives of heart […]

Read More

UKTI Vacancy: Northern Powerhouse Life Sciences Specialist

UK Trade & Investment (UKTI) Investment Group (IG) is creating a new team of specialists to work across the North to drive foreign direct investment into the region. UKTI’s goal is to support the wider rebalancing of the UK economy by attracting high-value (capital investment projects typically on the scale of ten million pounds and/or […]

Read More
Quantum Imaging Limited raises £4.6 million in series “A” funding round

Quantum Imaging Limited raises £4.6 million in series “A” funding round

Quantum Imaging Ltd., the UK – based medical device company working to reduce A&E congestion by developing an imaging device to rapidly triage patients presenting with chest pain, has announced completion of a new £4.6m investment with participation from all existing and new investors to further drive product commercialisation.

Read More
back to top